Advertisement

Topics

ProCertus BioPharm, Inc. Company Profile

17:51 EST 15th December 2018 | BioPortfolio

ProCertus BioPharm is an oncology-based pharmaceutical company whose primary mission is to protect cancer patients against the side effects of chemotherapy and radiotherapy.

ProCertus has established proof of concept in animal models for its product candidates, DermX, ProDermaCel™, and OralX, proprietary pharmaceuticals designed to reduce or eliminate the side effects associated with cancer therapy. ProDermaCel™ will protect cancer patients from chemotherapy- and radiotherapy-induced alopecia (hair loss), DermX will prevent radiotherapy-induced dermatitis (skin burn), and OralX will protect against chemotherapy- and radiotherapy-induced oral mucositis.

Location

Suite 175 B510 Charmany Drive
Madison
Wisconsin
53719
United States of America

Contact

Phone: (608) 277-7950
Fax: (608) 277-8041
Email: fahl@procertus.com


News Articles [62 Associated News Articles listed on BioPortfolio]

Win a FREE TICKET to BioPharm America 2018

If you haven’t heard of BioPharm America™, here’s what you need to know: BioPharm America is an international partnering conference with a focus on the life science industry. The conferen...

Tot Biopharm launches mAb manufacturing plant in China

Tot Biopharm has opened its second monoclonal antibody (mAb) production plant in Suzhou Industrial Park, China.

#jobs #lifescience BioPharm/BioTech

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: BioPharm/BioTech .MA-Cambridge, BioPharma/BioTech BIOPHARMA/BIOTECH Amgen, In...

#jobs #lifescience Covance UK: Lead Scientist (BioPharm CMC)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Covance UK: Lead Scientist (BioPharm CMC) . competitve with benefits: Covance...

Tot Biopharm of Suzhou Closes $102 Million Round for Cancer Drugs

Tot Biopharm of Suzhou closed a $102 million Series B financing round, which it will use to develop a portfolio of high-end anti-tumor drugs. Tot Bio has over ten drugs in the R&D stage, including...

Tot Biopharm Opens New Biologics Facility in Suzhou

Tot Biopharm, a Suzhou oncology company, completed a monoclonal antibodies (mAb) manufacturing facility. The 13,000 square meter site will have a capacity of 16,000L when it is completely built out. T...

PiSA BioPharm debuts line of Empty TPN bags at the ASHP Midyear 2018 Clinical Meeting

PiSA BioPharm, an emerging medical device and pharmaceutical company, announced today at the American Society of Health-System Pharmacists Midyear 2018 Clinical Meeting and Exhibi...

Movers and Shakers for Sept. 4

Biopharm companies closed out August with a plethora of changes to executive and senior leadership positions. Let's take a look.

Drugs and Medications [0 Results]

None

PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Corrigendum to "An insight of in vitro transport of PEGylated non-ionic surfactant vesicles (NSVs) across the intestinal polarized enterocyte monolayers" Eur. J. Pharm. Biopharm. 127 (2018) 432-442.

\TSNAdb: A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis.

Tumor-specific neoantigens have attracted much attention since they can be used as biomarkers to predict therapeutic effects of immune checkpoint blockade therapy and as potential targets for cancer i...

Staphylococcus aureus colonization and risk of surgical site infection in children undergoing clean elective surgery: A cohort study.

Staphylococcus aureus persistently colonizes the skin and nasopharynx of approximately 20% to 30% of individuals, with the highest rates in younger children. To avoid clinical problems for carriers an...

Curcumin loaded selenium nanoparticles synergize the anticancer potential of doxorubicin contained in self-assembled, cell receptor targeted nanoparticles.

Doxorubicin (DOX) has been extensively used to treat a wide range of cancers in free and nanotized form. Nanotization of Doxorubicin (DOX) has alleviated its toxicity and efflux-mediated resistance. H...

Clinical Trials [0 Results]

None

Companies [34 Associated Companies listed on BioPortfolio]

ProCertus BioPharm, Inc.

ProCertus BioPharm is an oncology-based pharmaceutical company whose primary mission is to protect cancer patients against the side effects of chemotherapy and radiotherapy.ProCertus has established p...

BioPharm Services US

BioPharm Services was first registered in 1998 and now employs more than 10 people in 2 offices in the US and UK. The company provides a broad spectrum of consultancy services covering all aspects of ...

R-Biopharm Inc.

R-Biopharm AG was founded in 1988 as a subsidiary of the company Röhm AG in Darmstadt. In 1991 R-Biopharm was acquired by Dr. Ralf Dreher through a management buy out. The main activity is the develo...

TTY Biopharm

TTY Biopharm stands to innovate the industry,emerge anew from the ashes of self-kindled flames, and accept multi challenges, encourage enterprising ventures, and share its knowledge and information.

Biopharm

Biopharm is a multinational company founded in 1995 by a group of scientists and business executives with the vision of developing innovative natural nutraceuticals that are backed by solid scientific...

More Information about "ProCertus BioPharm, Inc." on BioPortfolio

We have published hundreds of ProCertus BioPharm, Inc. news stories on BioPortfolio along with dozens of ProCertus BioPharm, Inc. Clinical Trials and PubMed Articles about ProCertus BioPharm, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ProCertus BioPharm, Inc. Companies in our database. You can also find out about relevant ProCertus BioPharm, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record